{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:27:17Z","timestamp":1767634037295,"version":"3.48.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J011567"],"award-info":[{"award-number":["2024J011567"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1245\/s10434-025-18592-z","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:28:01Z","timestamp":1761154081000},"page":"1694-1705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Hyperthermic Intraperitoneal Chemotherapy After Laparoscopic Gastrectomy in Gastric Cancer with Positive Peritoneal Lavage Cytology and no Other Noncurative Factors"],"prefix":"10.1245","volume":"33","author":[{"given":"Chenbin","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"3","key":"18592_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"18592_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5230\/jgc.2024.24.e18","volume":"24","author":"JY Yang","year":"2024","unstructured":"Yang JY, Park JH, Choi SJ, Lee WK. Role of recurrence pattern multiplicity in predicting post-recurrence survival in patients who underwent curative gastrectomy for gastric cancer. J Gastric Cancer. 2024;24(2):231\u201342. https:\/\/doi.org\/10.5230\/jgc.2024.24.e18.","journal-title":"J Gastric Cancer."},{"issue":"12","key":"18592_CR3","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1245\/s10434-010-1183-0","volume":"17","author":"JJ Mezhir","year":"2010","unstructured":"Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17(12):3173\u201380. https:\/\/doi.org\/10.1245\/s10434-010-1183-0.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"18592_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108059","volume":"50","author":"B Huang","year":"2024","unstructured":"Huang B, Rampulla V, Ri M, Lindblad M, Nilsson M, Rouvelas I, Klevebro F. Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer. Eur J Surg Oncol. 2024;50(6):108059. https:\/\/doi.org\/10.1016\/j.ejso.2024.108059.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"18592_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1245\/s10434-019-07697-x","volume":"27","author":"T Yamaguchi","year":"2020","unstructured":"Yamaguchi T, Takashima A, Nagashima K, Makuuchi R, Aizawa M, Ohashi M, et al. efficacy of postoperative chemotherapy after resection that leaves no macroscopically visible disease of gastric cancer with positive peritoneal lavage cytology (CY1) or localized peritoneum metastasis (P1a): a multicenter retrospective study. Ann Surg Oncol. 2020;27(1):284\u201392. https:\/\/doi.org\/10.1245\/s10434-019-07697-x.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"18592_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4251\/wjgo.v13.i1.24","volume":"13","author":"WZ Kang","year":"2021","unstructured":"Kang WZ, Zhong YX, Ma FH, Xue LY, Xiong JP, Ma S, et al. Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy. World J Gastrointest Oncol. 2021;13(1):24\u201336. https:\/\/doi.org\/10.4251\/wjgo.v13.i1.24.","journal-title":"World J Gastrointest Oncol."},{"issue":"9","key":"18592_CR7","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.21873\/anticanres.17198","volume":"44","author":"T Aoyama","year":"2024","unstructured":"Aoyama T, Maezawa Y, Hashimoto I. Open, Laparoscopy-assisted, robotic-assisted distal gastrectomy for gastric cancer: evidence from randomized clinical trials. Anticancer Res. 2024;44(9):3737\u201345. https:\/\/doi.org\/10.21873\/anticanres.17198.","journal-title":"Anticancer Res."},{"issue":"1","key":"18592_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1186\/s12885-024-12669-w","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lei X, Shan F, Li S, Jia Y, Miao R, et al. Long-term outcomes of laparoscopic versus open total gastrectomy in patients with advanced gastric cancer after neoadjuvant chemotherapy: a retrospective cohort study. BMC Cancer. 2024;24(1):1074. https:\/\/doi.org\/10.1186\/s12885-024-12669-w.","journal-title":"BMC Cancer."},{"issue":"8","key":"18592_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00595-012-0338-y","volume":"43","author":"N Yamanaka","year":"2013","unstructured":"Yamanaka N, Nagai E, Ohuchida K, et al. Feasibility of laparoscopic gastrectomy for advanced gastric cancer with positive peritoneal cytology. Surg Today. 2013;43(8):859\u201364. https:\/\/doi.org\/10.1007\/s00595-012-0338-y.","journal-title":"Surg Today."},{"issue":"7","key":"18592_CR10","doi-asserted-by":"publisher","first-page":"znae49","DOI":"10.1093\/bjs\/znae149","volume":"111","author":"A Brandl","year":"2024","unstructured":"Brandl A, van Sandick JW. Treatment of gastric cancer peritoneal metastases: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2024;111(7):znae49. https:\/\/doi.org\/10.1093\/bjs\/znae149.","journal-title":"Br J Surg."},{"key":"18592_CR11","doi-asserted-by":"publisher","first-page":"goae001","DOI":"10.1093\/gastro\/goae001","volume":"12","author":"T Lin","year":"2024","unstructured":"Lin T, Chen X, Xu Z, et al. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with intraoperative detection of limited peritoneal metastasis: a Phase II study of CLASS-05 trial. Gastroenterol Rep (Oxf). 2024;12:goae001. https:\/\/doi.org\/10.1093\/gastro\/goae001.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"6","key":"18592_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134. https:\/\/doi.org\/10.1245\/s10434-010-0985-4.","journal-title":"Ann Surg Oncol"},{"key":"18592_CR13","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association. 2023 Japanese Gastric Cancer Treatment Guidelines 2021 (6th edn). Gastric Cancer.;26(1):1-25 https:\/\/doi.org\/10.1007\/s10120-022-01331-8.","DOI":"10.1007\/s10120-022-01331-8"},{"issue":"1","key":"18592_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr (Engl Ed). 2021;112(1):90\u20132. https:\/\/doi.org\/10.1016\/j.ad.2019.05.009.","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"issue":"2","key":"18592_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"issue":"10","key":"18592_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108569","volume":"50","author":"K van der Sluis","year":"2024","unstructured":"van der Sluis K, Vollebergh MA, Kodach LL, van Dieren JM, de Hingh I, Wijnhoven BPL, et al. The clinical implications of staging laparoscopy in the diagnostic workup of gastric cancer patients: A population based study. Eur J Surg Oncol. 2024;50(10):108569. https:\/\/doi.org\/10.1016\/j.ejso.2024.108569.","journal-title":"Eur J Surg Oncol."},{"issue":"12","key":"18592_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.5340","volume":"156","author":"EC Gertsen","year":"2021","unstructured":"Gertsen EC, Brenkman HJF, van Hillegersberg R, van Sandick JW, van Berge Henegouwen MI, et al. 18F-Fludeoxyglucose-positron emission tomography\/computed tomography and laparoscopy for staging of locally advanced gastric cancer: a multicenter prospective Dutch cohort study (PLASTIC). JAMA Surg. 2021;156(12):e215340. https:\/\/doi.org\/10.1001\/jamasurg.2021.5340.","journal-title":"JAMA Surg."},{"issue":"4","key":"18592_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108233","volume":"50","author":"SJM van Hootegem","year":"2024","unstructured":"van Hootegem SJM, Chmelo J, van der Sluis PC, Lagarde SM, Phillips AW, Wijnhoven BPL. The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study. Eur J Surg Oncol. 2024;50(4):108233. https:\/\/doi.org\/10.1016\/j.ejso.2024.108233.","journal-title":"Eur J Surg Oncol."},{"issue":"7","key":"18592_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65832","volume":"16","author":"D Hac\u0131o\u011flu","year":"2024","unstructured":"Hac\u0131o\u011flu D, Guler E, G\u00fcm\u00fc\u015f T, Ersin S, F\u0131rat \u00d6, \u00d6zg\u00fcr Sezer T. Comparison of peritoneal cytology results before and after resection in gastric cancer patients. Cureus. 2024;16(7):e65832. https:\/\/doi.org\/10.7759\/cureus.65832.","journal-title":"Cureus."},{"issue":"6","key":"18592_CR20","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s13304-022-01376-5","volume":"74","author":"H Deng","year":"2022","unstructured":"Deng H, Li B, Qin X. The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with\/without peritoneal carcinomatosis: A systematic review and meta-analysis of randomized controlled trials. Updates Surg. 2022;74(6):1805\u201316. https:\/\/doi.org\/10.1007\/s13304-022-01376-5.","journal-title":"Updates Surg."},{"issue":"8","key":"18592_CR21","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1097\/JS9.0000000000000457","volume":"109","author":"M Patel","year":"2023","unstructured":"Patel M, Arora A, Mukherjee D, Mukherjee S. Effect of hyperthermic intraperitoneal chemotherapy on survival and recurrence rates in advanced gastric cancer: a systematic review and meta-analysis. Int J Surg. 2023;109(8):2435\u201350. https:\/\/doi.org\/10.1097\/JS9.0000000000000457.","journal-title":"Int J Surg."},{"issue":"7","key":"18592_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.gassur.2024.04.007","volume":"28","author":"M Stefano","year":"2024","unstructured":"Stefano M, Perrina D, Vallicelli C, et al. Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials. J Gastrointest Surg. 2024;28(7):1185\u201393. https:\/\/doi.org\/10.1016\/j.gassur.2024.04.007.","journal-title":"J Gastrointest Surg."},{"issue":"2","key":"18592_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.21037\/jgo-23-886","volume":"15","author":"Y Shen","year":"2024","unstructured":"Shen Y, Yu S, Zhang Y, et al. The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database. J Gastrointest Oncol. 2024;15(2):597\u2013611. https:\/\/doi.org\/10.21037\/jgo-23-886.","journal-title":"J Gastrointest Oncol."},{"issue":"3","key":"18592_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10120-012-0156-3","volume":"15","author":"Y Kodera","year":"2012","unstructured":"Kodera Y, Ito S, Mochizuki Y, et al. Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study. Gastric Cancer. 2012;15(3):335\u20137. https:\/\/doi.org\/10.1007\/s10120-012-0156-3.","journal-title":"Gastric Cancer."},{"issue":"1","key":"18592_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12957-023-03085-8","volume":"21","author":"B Li","year":"2023","unstructured":"Li B, Miao R, Shan F, et al. Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology. World J Surg Oncol. 2023;21(1):204. https:\/\/doi.org\/10.1186\/s12957-023-03085-8.","journal-title":"World J Surg Oncol."},{"issue":"4","key":"18592_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jso.26770","volume":"125","author":"H Kobayashi","year":"2022","unstructured":"Kobayashi H, Honda M, Kawamura H, et al. Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination. J Surg Oncol. 2022;125(4):615\u201320. https:\/\/doi.org\/10.1002\/jso.26770.","journal-title":"J Surg Oncol."},{"issue":"1","key":"18592_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1245\/s10434-024-16328-z","volume":"32","author":"AB Hamed","year":"2025","unstructured":"Hamed AB, El Asmar R, Tirukkovalur N, et al. Insight into predictors of cytoreduction score following cytoreductive surgery-hyperthermic intraperitoneal chemotherapy for gastric peritoneal carcinomatosis improves patient selection and prognostic outcomes. Ann Surg Oncol. 2025;32(1):199\u2013208. https:\/\/doi.org\/10.1245\/s10434-024-16328-z.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"18592_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1200\/JCO.22.02867","volume":"42","author":"B Rau","year":"2024","unstructured":"Rau B, Lang H, Koenigsrainer A, et al. Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the Phase III GASTRIPEC-I trial. J Clin Oncol. 2024;42(2):146\u201356. https:\/\/doi.org\/10.1200\/JCO.22.02867.","journal-title":"J Clin Oncol."},{"issue":"11","key":"18592_CR29","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.ejso.2021.05.016","volume":"47","author":"S Granieri","year":"2021","unstructured":"Granieri S, Bonomi A, Frassini S, et al. Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials. Eur J Surg Oncol. 2021;47(11):2757\u201367. https:\/\/doi.org\/10.1016\/j.ejso.2021.05.016.","journal-title":"Eur J Surg Oncol."},{"issue":"20","key":"18592_CR30","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3390\/jcm12206527","volume":"12","author":"AJ Jain","year":"2023","unstructured":"Jain AJ, Badgwell BD. Current evidence for the use of HIPEC and cytoreductive surgery in gastric cancer metastatic to the peritoneum. J Clin Med. 2023;12(20):6527. https:\/\/doi.org\/10.3390\/jcm12206527.","journal-title":"J Clin Med."},{"issue":"13","key":"18592_CR31","doi-asserted-by":"publisher","first-page":"8549","DOI":"10.1245\/s10434-024-16142-7","volume":"31","author":"A Khomiak","year":"2024","unstructured":"Khomiak A, Ghaffar S, Rodriguez Franco S, et al. survival outcomes of cytoreductive surgery with HIPEC in gastric adenocarcinoma: A National Cancer Database Study. Ann Surg Oncol. 2024;31(13):8549\u201359. https:\/\/doi.org\/10.1245\/s10434-024-16142-7.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"18592_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/02656736.2022.2028018","volume":"39","author":"L Liu","year":"2022","unstructured":"Liu L, Sun L, Zhang N, et al. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer. Int J Hyperthermia. 2022;39(1):239\u201345. https:\/\/doi.org\/10.1080\/02656736.2022.2028018.","journal-title":"Int J Hyperthermia."},{"issue":"5","key":"18592_CR33","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1245\/s10434-021-11316-z","volume":"29","author":"JF Zhang","year":"2022","unstructured":"Zhang JF, Lv L, Zhao S, Zhou Q, Jiang CG. Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: A 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages. Ann Surg Oncol. 2022;29(5):3170\u201386. https:\/\/doi.org\/10.1245\/s10434-021-11316-z.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"18592_CR34","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.1007\/s00432-023-05019-z","volume":"149","author":"P Yu","year":"2023","unstructured":"Yu P, Huang X, Huang L, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study. J Cancer Res Clin Oncol. 2023;149(13):11491\u20138. https:\/\/doi.org\/10.1007\/s00432-023-05019-z.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"11","key":"18592_CR35","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","volume":"24","author":"B Badgwell","year":"2017","unstructured":"Badgwell B, Blum M, Das P, et al. Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma. Ann Surg Oncol. 2017;24(11):3338\u201344. https:\/\/doi.org\/10.1245\/s10434-017-6047-4.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"18592_CR36","doi-asserted-by":"publisher","first-page":"840","DOI":"10.5306\/wjco.v15.i7.840","volume":"15","author":"A Methasate","year":"2024","unstructured":"Methasate A, Parakonthun T, Intralawan T, Nampoolsuksan C, Swangsri J. Impact of hyperthermic intraperitoneal chemotherapy on gastric cancer survival: Peritoneal metastasis and cytology perspectives. World J Clin Oncol. 2024;15(7):840\u20137. https:\/\/doi.org\/10.5306\/wjco.v15.i7.840.","journal-title":"World J Clin Oncol."},{"issue":"6","key":"18592_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21037\/cco-23-90","volume":"12","author":"C Chen","year":"2023","unstructured":"Chen C, Justo M, Gangi A. Hyperthermic intraperitoneal chemotherapy for gastric cancer: A narrative review. Chin Clin Oncol. 2023;12(6):68. https:\/\/doi.org\/10.21037\/cco-23-90.","journal-title":"Chin Clin Oncol."},{"issue":"3","key":"18592_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41416-024-02731-6","volume":"131","author":"SL Aronson","year":"2024","unstructured":"Aronson SL, Walker C, Thijssen B, et al. Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1). Br J Cancer. 2024;131(3):565\u201376. https:\/\/doi.org\/10.1038\/s41416-024-02731-6.","journal-title":"Br J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18592-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:09:21Z","timestamp":1767618561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18592-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18592"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18592-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This study was approved by the Ethics Committee of Zhangzhou Hospital Affiliated to Fujian Medical University (2024LWB345). Informed consent was obtained from all subjects and\/or their legal guardian(s). All procedures were undertaken in accordance with the Helsinki Declaration and all methods were carried out in accordance with relevant guidelines and regulations in the declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}